Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents 2008;33:307-20. [PMID: 19108994 DOI: 10.1016/j.ijantimicag.2008.10.010] [Citation(s) in RCA: 398] [Impact Index Per Article: 24.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2008] [Accepted: 10/01/2008] [Indexed: 11/25/2022]

For:	De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents 2008;33:307-20. [PMID: 19108994 DOI: 10.1016/j.ijantimicag.2008.10.010] [Citation(s) in RCA: 398] [Impact Index Per Article: 24.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2008] [Accepted: 10/01/2008] [Indexed: 11/25/2022]

Number

Cited by Other Article(s)

401

De Clercq E. Antiviral chemotherapy in 2009: quo vadis? Future Virol 2009. [DOI: 10.2217/fvl.09.23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]

402

Chapter 1 Looking Back in 2009 at the Dawning of Antiviral Therapy Now 50 Years Ago. Adv Virus Res 2009;73:1-53. [DOI: 10.1016/s0065-3527(09)73001-5] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]